Vir Biotechnology is a clinical-stage biopharmaceutical company focused on powering the immune system to transform lives by discovering and developing medicines for serious infectious diseases and cancer. Its clinical-stage portfolio includes programs for chronic hepatitis delta and multiple dual-masked T-cell engagers across validated targets in solid tumor indications. Vir Biotechnology also has a preclinical portfolio of programs across a range of infectious diseases and oncologic malignancies.
We believe the success of our colleagues drives the success of our mission. We are committed to creating a company where everyone feels supported and encouraged to give their best.
Vir Biotechnology is looking for an experienced Senior Director, Investor Relations, to join our team. Reporting to the Chief Financial Officer, you will set the strategic direction for the Investor Relations function and play a pivotal role in championing the story of our science, pipeline, and impact to the investment community.
In this key leadership position, you will collaborate across research, development, executive leadership, and corporate communications to translate complex scientific, clinical, business and financial information into compelling, impactful narratives. As the primary contact for investors, analysts, and other key external stakeholders, you will drive the development of strategic communications and provide actionable insights that shape Vir Bio’s external reputation and support our continued growth.
This role is located in our San Francisco headquarters with an expectation of at least 3 days per week in office.
WHAT YOU'LL DO- Develop and execute an annual investor relations strategy that effectively communicates Vir Bio’s short and long-term vision, corporate goals, and scientific progress to the investment community
- Continuously monitor internal developments, external market events, and shareholder trends for Vir Bio and its peers to inform and adapt investor relations strategy, ensuring messaging and targeting remain relevant and impactful
- Analyze shareholder base and investment trends for Vir Bio and its peers to inform investor targeting strategy, monitor its effectiveness, and identify proactive opportunities to engage with the investment community
- Partner with executive leadership and cross-functional teams to ensure consistency and alignment of messaging and disclosure across all investor materials and presentations
- Lead investor engagement activities, including organizing banking conferences, non-deal roadshows, R&D and analyst days, bus tours, and one-on-one meetings with the investment community, along with research or clinical investor events
- Partner with the CFO as the main point of contact for sell-side analysts, actively engaging to convey Vir Bio’s strategy and key messages. Collect and assess sell-side models, compare them to internal forecasts, and use these insights to inform analyst and investor communications
- Lead investor communications, including corporate presentation decks, management Q&As, website content, the business section of Form 10-K, and other matters as required
- Prepare earnings releases and investor conference call scripts and coach leaders for effective delivery
- Contribute to Board materials, other company press releases, and SEC documents (e.g., Form 8- Ks, Form S-3 fillings)
- Create briefing materials for management in preparation for investor meetings
- Collaborate with cross-functional partners—including Competitive Intelligence, legal, and corporate communications—to monitor industry trends, ensure regulatory compliance, deliver key events like the annual stockholder meeting, and maintain accurate, consistent messaging across all external communications
- BA/BS required, MBA, M.D., or relevant Ph.D. preferred
- Minimum 10 years of investor relations experience in a publicly traded biotech or pharmaceutical company, at an investor relations firm working with biotech or pharmaceutical clients, or on the buy or sell-side working in biotech or pharmaceuticals
- Ability to present and respond to questions regarding complex scientific and clinical data
- Deep understanding of capital markets, financial statements and valuation models used by investors and analysts
- Well versed in SEC and FDA regulations impacting investor and other external communications
- Exceptional communication abilities, strong financial acumen (including valuation and financial modeling), and a strategic mindset
- Highly collaborative working style across internal and external teams
- Strong network and relationships with influencers in the scientific and healthcare community
- Highly organized and structured, able to manage and guide complex investor communication events, often with multiple competing priorities
The expected salary range for this position is $227,500.00 to $318,000.00. Actual pay will be determined based on experience, qualifications, geographic location, and other job-related factors.
Vir Biotechnology's compensation and benefits are aligned with the current market and commensurate with the person’s experience and qualifications. All full-time employees receive a package that includes compensation, bonus and equity as well as many other Vir Biotechnology benefits and perks such as health and welfare benefit plans, non-accrual paid time off, company shut down for holidays, commuter benefits, childcare reimbursement, education reimbursement, 401K match and lunch each day in the office.
Applicants must currently be authorized to work for any employer in the U.S. We are unable to sponsor or take over sponsorship of an employment Visa at this time.
All employment decisions at Vir Biotechnology are based on legitimate, non-discriminatory business requirements, job duties and individual qualifications. Employment decisions are made without regard to any legally protected characteristics.
This commitment extends to all management practices and decisions, including recruitment and hiring, compensation, appraisal systems, promotions, training and career development programs. Vir Biotechnology also strongly commits to providing employees with a work environment free of unlawful conduct or harassment.
Vir Biotechnology Human Resources leads recruitment and employment for Vir Biotechnology. Unsolicited resumes sent to the company from recruiters do not constitute any type of relationship between the recruiter and Vir Biotechnology and do not obligate us to pay fees should we hire from those resumes. We ask that external recruiters and/or agencies not contact or present candidates directly to our hiring manager or employees.
For hires based in the United States, Vir Biotechnology, participates in E-Verify.
Candidate Privacy Notice
What We Do
Vir Biotechnology, Inc. (in Europe, Humabs BioMed, https://bit.ly/46lQGN2) is an immunology company focused on powering the immune system to address unmet patient needs in infectious disease and beyond. Our powerful R&D engine combines our proprietary monoclonal antibody (mAb) platform with machine learning and artificial intelligence-enhanced capabilities, enabling us to engineer our rich database of human antibodies and deliver transformative medicines for diseases with significant global burden.
Our current pipeline consists of multiple clinical candidates targeting hepatitis B and hepatitis delta viruses and human immunodeficiency virus, including a potential functional cure for chronic hepatitis B and treatment for chronic hepatitis delta. Our portfolio of broad, potent investigational monoclonal antibodies also targets influenza A and B viruses, COVID-19, respiratory syncytial virus/human metapneumovirus and human papillomavirus, and our investigational T cell vaccine aims to prevent HIV. Explore our full pipeline: https://bit.ly/3tr7FPm
We collaborate with some of the world’s leaders in industry as well as government agencies and non-profit organizations enabling us to rapidly advance cutting-edge scientific discoveries and innovative technologies with the potential to benefit people around the world.
We are proud to have been ranked the fastest-growing company in North America on the 2022 Deloitte Technology Fast 500™.
Join us as we pursue our mission to transform lives.
It has come to our attention that there have been various recruitment scams targeting job seekers on LinkedIn. Vir Biotechnology, Inc. is committed to your privacy and will never request sensitive personal information including banking details through email, text message, social media or video software platforms. We also will never request a financial commitment from a candidate as part of the application process. Learn more about Vir’s recruiting process: https://bit.ly/461EgJN
